share_log

Benchmark Reiterates Speculative Buy on Milestone Scientific, Maintains $1.25 Price Target

Benzinga ·  Nov 20 21:22  · Ratings

Benchmark analyst Bruce Jackson reiterates Milestone Scientific (AMEX:MLSS) with a Speculative Buy and maintains $1.25 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment